Intra-Cellular Therapies
ITCI
#2214
Rank
$6.69 B
Marketcap
$69.20
Share price
-0.75%
Change (1 day)
24.17%
Change (1 year)

Intra-Cellular Therapies (ITCI) - Total liabilities

Total liabilities on the balance sheet as of December 2023 : $0.13 B

According to Intra-Cellular Therapies's latest financial reports the company's total liabilities are $0.13 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Intra-Cellular Therapies - Total liabilities on balance sheet (from 2013 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-12-31$0.13 B38.66%
2022-12-31$98.71 M37.04%
2021-12-31$72.03 M19.15%
2020-12-31$60.45 M7.61%
2019-12-31$56.17 M42.26%
2018-12-31$39.49 M131.63%
2017-12-31$17.04 M27.23%
2016-12-31$13.4 M70.48%
2015-12-31$7.86 M-25.54%
2014-12-31$10.55 M54.48%
2013-12-31$6.83 M140.67%
2013-03-31$0.02 M
2012-12-31$2.83 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$0.28 B 107.17%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.89 M-97.16%๐Ÿ‡บ๐Ÿ‡ธ USA
$57.61 M-57.91%๐Ÿ‡บ๐Ÿ‡ธ USA